Priority Date: 23.08.11 (JP 20110181683)

NOVEL ANTI-DDR1 ANTIBODY HAVING ANTI-TUMOR ACTIVITY

  • Application ID: EP12826213
  • Status: EXAMINATION IN PROGRESS

Attorney

operating since 2003
Headquarter in Mannheim and 4 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC class A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 133 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 23.08.2011 - Priority Date (JP 20110181683)
  • 28.02.2013 - Publication A1 (WO2013027802)
  • 02.07.2014 - Publication A1 (EP2749572)